Blog Posts in 2011
Posted on Nov 21, 2011 By Jennifer Williams
An article out today on Bloomberg.com states that units of Bayer AG, Germany's largest drug maker, may have promoted its birth control pills, Yasmin and Yaz, for unapproved uses. The article also ...
Continue reading "New Article Suggests Bayer May Have Promoted Yaz/Yasmin for Unapproved Use" »
Posted on Nov 8, 2011 By Jennifer Williams
A new study published November 6, 2011 in the Canadian Medical Association Jounral links oral contraceptives containing drospirenone (Yaz, Yasmin, Ocella, Beyaz) with a higher risk of venous ...
Continue reading "New Study of Irsaeli Women Reveals Increased Risk of DVT and Pulmonary Embolism in Yaz/Yasmin Users" »
Posted on Oct 27, 2011 By Jennifer Williams
The FDA released the report today from its study of the relative risks of various combined hormonal contraceptives (CHCs). The study compared recently marketed CHCs including Yasmin/Yaz, Ortho Evra ...
Continue reading "Report from FDA-funded study confirms increased risk of VTEs in users of Yasmin and Yaz" »
Posted on Oct 26, 2011 By Allen Law Firm
A new study published in the British Medical Journal today confirms previous studies that concluded users of Yaz and Yasmin are at least at twice the risk of venous thromboembolism compared with users ...
Continue reading "New Danish Study Confirms Increased Risk of Venous Thromboembolism in Yaz / Yasmin Users" »
Posted on Sep 27, 2011 By Jennifer Williams
On September 26, 2011 the FDA issued a Drug Safety Communication regarding its safety review of drospirenone-containing oral contraceptives such as Yasmin and Yaz. The FDA bulletin states that while ...
Continue reading "FDA to Convene Panel to Weigh Risks of Yasmin and Yaz" »
Posted on Aug 26, 2011 By Jennifer Williams
In Order handed down on August 18, 2011, Judge Herndon, presiding Judge of the Yaz/Yasmin federal court litigation, indicated that he is working on a plan to "engage the parties in settlement ...
Continue reading "Judge Says He Will Push Settlement Negotiations Following Bellwether Trials" »
Posted on Aug 4, 2011 By Jennifer Williams
The New Jersey court in charge of the Yaz/Yasmin consolidated litigation in that state has recently issued a bellwether trial schedule. The plan laid out in Case Management Order 25 sets the first ...
Continue reading "Bellwether Trial Schedule Set for New Jersey Litigation" »
Posted on Jun 14, 2011 By Jennifer Williams, Esq.
On June 9, 2011, Judge Herndon set the bellwether trial schedule for the Yaz / Yasmin litigation in the federal court multidistrict litigation (MDL). The first case set for trial involves a young ...
Continue reading "MDL Bellwether Trial Schedule Set" »
Posted on Jun 1, 2011 By Jackson Allen Williams, LLP
On May 31, 2011 the FDA issued a safety alert warning of a possible increased risk of blood clots associated with birth control pills containing drospirenone. Drospirenone is a hormone found in the ...
Continue reading "FDA Warns of Increased Risk of Blood Clots with Yaz and Yasmin" »
Posted on Apr 25, 2011 By Jackson Allen Williams, LLP
April 25, 2011 - Two articles published in British Medical Journal over the weekend confirm previous studies that show an increased risk of venous thromboembolic events including stroke , pulmonary ...
Continue reading "Two New Articles Confirm Increased Risk of Venous Thromboembolism in Yaz & Yasmin Users" »
Posted on Apr 19, 2011 By Jackson Allen Williams, LLP
On April 18, 2011 the Canadian Medical Association Journal published an article that reports a statistically significant increase in the risk of gallbladder diseases associated with dropserinone, ...
Continue reading "Yaz/Yasmin May Put Women at Increased Risk for Gallbladder Disease" »
Posted on Jan 7, 2011 By Yaz Lawyers
The Pennsylvania State Court Judge Sandra Moss overseeing the consolidated litigation involving Yaz and Yasmin birth control pills has established a bellwether trial schedule similar to the one ...
Continue reading "Bellwether Trial Schedule Established for Yaz, Yasmin Cases in Pennsylvania" »